Syneos Health (formerly INC Research) VP of Sales Salaries in Raleigh-Durham, NC
The average Syneos Health (formerly INC Research) VP of Sales in Raleigh-Durham, NC earns an estimated $297,130 annually, which includes an estimated base salary of $188,734 with a $108,395 bonus. Syneos Health (formerly INC Research) VP of Sales compensation is $2,339,067 less than the US average for a VP of Sales. VP of Sales salaries at Syneos Health (formerly INC Research) in Raleigh-Durham, NC can range from $125,467 - $700,000.
In Raleigh-Durham, NC, The Sales Department at Syneos Health (formerly INC Research) earns $4,284 more on average than the Marketing Department.
Last updated 2 years ago.
- $188,734
- avg. base
- $108,395
- avg. bonus
VP of Sales Salaries at Syneos Health (formerly INC Research)
In Raleigh-Durham, NC, VPs of Sales earn $63,968 more than Directors of Sales.
Compensation at Syneos Health (formerly INC Research) by Department
In Raleigh-Durham, NC, The Sales Department averages $4,284 more than the Marketing Department, and $5,688 less than the Engineering Department
VP of Sales Compensation by Gender (All Companies)
The average female VP of Sales at companies similar size to Syneos Health (formerly INC Research) reported making $326,625, while the average male VP of Sales at similar sized companies reported making $314,005.
VP of Sales Compensation by Ethnicity (All Companies)
The average Hispanic or Latino VP of Sales at companies similar size to Syneos Health (formerly INC Research) reported making $371,333, while the average Asian or Pacific Islander VP of Sales at similar sized companies reported making $260,050.
How VPs of Sales at Syneos Health (formerly INC Research) Rate Their Compensation
The majority of VPs of Sales at Syneos Health (formerly INC Research) believe they're compensated fairly. 100% of VPs of Sales at Syneos Health (formerly INC Research) say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Syneos Health (formerly INC Research)
